课题基金 / 基金详情

Electrochemical drug sensing with hydrophobic compound-adapted aptamers**

Electrochemical drug sensing with hydrophobic compound-adapted aptamers**
使用疏水性化合物适配适配体进行电化学药物传感**
批准号:
521437-2018
负责人:
Perreault, Jonathan
金额:
$14.35万
依托单位国家:
加拿大
项目类别:
Strategic Projects - Group
财政年份:
2018
资助国家:
加拿大
项目状态:
已结题
起止时间:
2018-01-01 至 2019-12-31

项目摘要

项目成果

Perreault, Jonathan的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Drug usage is responsible for numerous adverse effects on public health and safety (overdoses, car accidents, crime...). Accordingly, simple and rapid detection of illicit drug smuggling and of drug usage during driving is of paramount importance. The latter is particularly relevant in the context of the expected 2018 marijuana legalization, accompanied with a so-called "zero-tolerance while driving" policy for which appropriate detection-technology is not currently available. Detection often relies on non-optimal targets. For example, studies indicate that to evaluate driving impairment induced by cannabis, it would be more appropriate to use a ratio of THC (the main active ingredient of marijuana) and metabolized THC molecules. In parallel, volatile derivatives of cocaine are more useful for detection of drug smuggling.** Most of the current portable technologies use antibodies, which do not discern THC from its metabolites and do not bind to the most volatile compounds derived from drugs (like cocaine derivatives). The hydrophobicity of these drugs and their derivatives poses technical problems to find biosensing-molecules that recognize them. We plan to overcome this challenge with modified aptamers (which are DNA molecules that recognize target analytes with a tailored selectivity) combined to an electrochemical platform for transduction of the binding event. The proposed advances are expected to lead to biosensors for simple, cheap, ultrasensitive and rapid drug detection which will help counter drug smuggling and provide much needed tools for cannabis testing for drivers.** The partnership with the two companies involved and the team put together to achieve these goals combines high level expertise and infrastructures that will provide an outstanding environment for the training of students and PDFs. In addition, it will contribute to keep Canada at the forefront of aptamer and biosensing research as well as provide technologies to solve very current problematics in Canada.******
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery and characterization of noncoding RNAs in prokaryotes
Discovery and characterization of noncoding RNAs in prokaryotes
Electrochemical drug sensing with hydrophobic compound-adapted aptamers
Sensitive and specific electrochemical detection of COVID-19 (SARS-CoV2) based on isothermal amplification
国内基金
海外基金
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
  • 批准号:
    82371102
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    苏蕴
  • 依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
  • 批准号:
    82371224
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马柯
  • 依托单位:
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    杨胜彩
  • 依托单位: